RPL39P26

Across TCGA pan-cancer cohorts, RPL39P26 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPL39P26 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPL39P26 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL39P26 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.

UCEC, LIHC, and HNSC are the cancer types where RPL39P26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	II,III,IV	0.090	0.522	<.001	84	view →
LIHC	DFS	Tertile	All	0.219	0.554	<.001	81	view →
HNSC	OS	Tertile	II,III,IV	0.240	0.631	<.001	66	view →
CESC	DFS	Tertile	III,IV	0.166	0.655	<.001	54	view →
LUAD	DFS	Tertile	All	0.845	0.638	.003	33	view →
UVM	OS	Tertile	All	0.265	0.699	.003	24	view →
DLBC	OS	Tertile	II,III,IV	0.664	0.965	.005	23	view →
THCA	OS	Tertile	IV	0.579	1.000	<.001	18	view →
PAAD	DFS	Tertile	All	0.253	0.534	.002	18	view →
READ	DFS	Tertile	IV	0.295	0.661	.021	15	view →
ESCA	OS	Median	III,IV	0.569	0.304	.004	11	view →
COAD	DFS	Tertile	II,III,IV	0.334	0.661	.023	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPL39P26–UCEC (DFS)

Open the UCEC breakdown →